Brice Emanuelli
Associate Professor
Emanuelli Group
Blegdamsvej 3B, Mærsk Tårnet, 7. sal, 2200 København N.
The prevalence of obesity and type 2 diabetes is rising at alarming rates worldwide, and urges for the discovery of new therapeutic options. These metabolic disorders are characterized by insulin resistance, i.e. an inappropriate response to insulin in its target tissues, including muscle, adipose tissues and liver.
The main research area of my group is the investigation of the molecular mechanisms involved in the transduction of insulin signalling and the regulation of metabolic processes.
In particular, we are interested in:
- Dissecting the signaling events mediating the various actions of insulin to control metabolic outcomes and cellular differentiation.
- Studying how the complex nature of the insulin signaling network is perturbed in conditions of insulin resistance.
Our molecular interrogation of the insulin signalling cascades aims to identify new avenues for the development of therapeutic strategies to treat insulin resistance with the long-term goal of preventing type 2 diabetes.
ID: 41852944
Most downloads
-
280
downloads
Cardiolipin Synthesis in Brown and Beige Fat Mitochondria Is Essential for Systemic Energy Homeostasis
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
244
downloads
Bidirectional manipulation of gene expression in adipocytes using CRISPRa and siRNA
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
100
downloads
Calsyntenin 3β Is Dynamically Regulated by Temperature in Murine Brown Adipose and Marks Human Multilocular Fat
Research output: Contribution to journal › Journal article › Research › peer-review
Published